Extent of exposure to DS-1205c
Overall, the median duration of DS-1205c treatment was 90 (range, 28–281) days, the median number of treatment cycles was 5 (range, 2–14), and the median relative DS-1205c dose intensity was 99.5% (range, 84.5–100%). Further details of exposure to DS-1205c, including by cohort, are provided in Table Exposure to DS-1205c (safety analysis set)